Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of September 9, 2026, TTRX trades at $13.20 with a market cap of $297.60M and a P/E ratio of -102.58. TTRX moved +0.00% today. Year to date, TTRX is +221.32%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest TTRX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $13.20 |
| Market Cap | $297.60M |
| P/E Ratio | -102.58 |
| EPS | $-0.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.50 |
| 52-Week Low | $2.57 |
| Volume | 7.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-3.19M |
| Gross Margin | 0.00% |
1 analysts cover TTRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.